The role of the microbiome in psoriasis: moving from disease description to treatment selection?

Ewan A LanganC E M GriffithsW SolbachJ K KnoblochD ZillikensD Thaçi

Published in: The British journal of dermatology (2018)

Ultimately, in the age of personalized medicine, the integration of cutaneous microbiome signatures and comprehensive disease and drug response endotypes will herald a novel approach in the clinical management of chronic multisystem inflammatory diseases.

Keyphrases

oxidative stress
gene expression
drug induced
combination therapy
replacement therapy